Disease-modifying therapies as cognition-modifying therapies? Treating cognitive impairment in MS

Marrie, RA; Leavitt, VM

Marrie, RA (corresponding author), Univ Manitoba, Dept Internal Med, Max Rady Coll Med, Rady Fac Hlth Sci, Winnipeg, MB, Canada.; Marrie, RA (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Max Rady Coll Med, Rady Fac Hlth Sci, Winnipeg, MB, Canada.

NEUROLOGY, 2020; 94 (22): 957

Abstract

Multiple sclerosis (MS) is characterized by a plethora of symptoms, including cognitive impairment. The prevalence of cognitive impairment ranges from......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索